Core Viewpoint - The company expects a net loss attributable to shareholders for the fiscal year 2025 to be between -160 million to -209 million yuan, indicating a reduction in loss compared to the previous year [1] Financial Performance - The projected non-recurring net profit is estimated to be between -180 million to -230 million yuan, which represents an increase in loss compared to the previous year [1] - The net profit for the same period last year was -209 million yuan [1] Reasons for Performance - The primary reasons for the expected loss include the transfer of part of the controlling subsidiary, expiration of business contracts without renewal, and industry policy impacts leading to revenue decline [1] - Increased research and development expenditures, as well as impairment of receivables and goodwill, are also contributing factors [1] - The valuation results of goodwill and other assets have not yet been determined, and final financial data will be based on the 2025 annual report [1]
塞力医疗:2025年度预计净亏损1.6亿-2.09亿元